Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness - Wikidata - awgldk - TriplyDB

Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness

Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness

http://www.wikidata.org/entity/Q34301819

about

Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat Cytokines as new treatment targets in chronic heart failure Clinical review: Myocardial depression in sepsis and septic shock Myocardial Dysfunction and Shock after Cardiac Arrest ASK1 associates with troponin T and induces troponin T phosphorylation and contractile dysfunction in cardiomyocytes Effects of burn injury on myocardial signaling and cytokine secretion: Possible role of PKC CXCR4 modulates contractility in adult cardiac myocytes Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Cardiac myosin binding protein C and MAP-kinase activating death domain-containing gene polymorphisms and diastolic heart failure.Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions.Infliximab attenuates early myocardial dysfunction after resuscitation in a swine cardiac arrest model.Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.Interleukin-1β reduces L-type Ca2+ current through protein kinase Cϵ activation in mouse heart.Glucocorticoids as an emerging pharmacologic agent for cardiopulmonary resuscitation.Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta Immune and neurohormonal pathways in chronic heart failure.Lipopolysaccharide and cytokines inhibit rat cardiomyocyte contractility in vitro Do cardiomyocytes mount an immune response to Group A Streptococcus?Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart.Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study.Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1 Sepsis-induced cardiomyopathy.Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?TNF and congestive heart failure: therapeutic possibilities.Cytokine mRNA expression in postischemic/reperfused myocardium.Case report: severe reversible cardiomyopathy associated with systemic inflammatory response syndrome in the setting of diabetic hyperosmolar hyperglycemic non-ketotic syndrome.Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells.Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6.Cytokines and cardiovascular disease.Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy Recent advances of TNF-alpha antagonists in rheumatoid arthritis and chronic heart failure.Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.Molecular events in the cardiomyopathy of sepsis.

P2860

Q21296645-068DEC57-D1BB-4132-A9FA-425FD2CD528E Q24673703-32144E5B-BA26-4513-972D-B0D8FED3D5CF Q24799394-33D395E8-3F43-486C-8C8F-9F9FEC9AC7AB Q24807147-43F9FE04-F04B-4FEB-900E-D08328F47573 Q26784080-89247C0C-D612-4EF3-9FBC-C784E2A9894D Q28180984-71B8E91D-B870-4C19-A3FF-408DC56B541C Q28575642-51B12775-E229-4E56-B97C-2C1D392B5921 Q28582056-105A958D-C322-4950-90BD-9F6C073AA8F7 Q28731260-D678206D-A3AD-4706-88C8-45D89C93099C Q30319434-1FCB9AD2-34A2-4C7B-A189-6F5172F9F184 Q31058267-104C111C-0932-42A0-8CA4-3095B8006737 Q31159585-4424E0C4-95D4-4259-B8FF-62844434C53C Q33753939-D99ADF0F-AE57-4CB1-9A3D-77686D627786 Q33826955-4E9C2F8A-268B-4C2D-8C1E-05301E57FDDF Q33907789-3A3D7165-2C43-4066-BFA9-BEAC90B0083B Q34070335-DBD0B4F4-1736-4C4A-8CED-762229F7B6BA Q34175968-08E88BF0-4580-49D3-9F20-CF911BAC8A9C Q34185457-8805906C-F1EB-4B95-B23B-5C22D65A1FBE Q34201359-A0DEDAF8-8805-419E-A9AC-EAF50DCBA4E3 Q34513186-D7044B2E-95A7-4B60-8BB7-15AC5297A65A Q34718320-E20A6F29-B5B3-4A6B-A410-57C3F9546259 Q34916463-33C36A91-9BA2-4739-ADCF-6AC2EBB694C2 Q35026157-1851FD00-A99E-48F2-BC3A-9AE98B959C72 Q35250425-A4A160AC-502A-4939-B073-FC42930FC2CA Q35536642-3CE8CD3F-0391-48A5-9A71-82B11A9EC77F Q35604862-B16964DC-BD57-427F-92AE-CB92A27C32C1 Q35609202-05B280FE-9CD8-44C0-BCFF-53BC93266C21 Q35687065-1CC9F7E3-AC4A-42E7-9E63-C9669ED837E7 Q35761448-55739A85-9BA0-4532-88ED-8796293121E3 Q35782883-677B83DC-4F64-4BB3-A7C2-78EB8E820E59 Q35796148-A54F1CF1-619D-403D-B407-609C073D46D0 Q35807000-1A5758F2-B088-49E0-A1A1-45F0D13337CB Q35872942-D277D288-2F08-4733-82CF-B6BD7EEFCFD7 Q36072891-CE69E3AD-8A4D-4CB2-8A9F-FEEB368A75AB Q36188431-DE427B9D-0D18-4864-B8D8-077DB5BCC2BE Q36204135-4B4EDAEA-6608-4176-896B-AB3A317BC0CE Q36698712-4EDF5098-49CC-42F0-967F-45BB519AFE0D Q36810269-BE05FADA-29DC-46C4-A0F6-498C31254D02 Q36833376-D54BF88A-05B3-422E-9D2F-663E30F78016 Q37078877-30B8316E-175D-4E01-88F5-E2CC94D9C583

P2860

Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness

http://www.wikidata.org/entity/Q34301819

description

1989 nî lūn-bûn

@nan

1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Interleukin 1 and tumor necros ...... beta-adrenergic responsiveness

@ast

Interleukin 1 and tumor necros ...... beta-adrenergic responsiveness

@en

Interleukin 1 and tumor necros ...... beta-adrenergic responsiveness

@nl

type

label

Interleukin 1 and tumor necros ...... beta-adrenergic responsiveness

@ast

Interleukin 1 and tumor necros ...... beta-adrenergic responsiveness

@en

Interleukin 1 and tumor necros ...... beta-adrenergic responsiveness

@nl

prefLabel

Interleukin 1 and tumor necros ...... beta-adrenergic responsiveness

@ast

Interleukin 1 and tumor necros ...... beta-adrenergic responsiveness

@en

Interleukin 1 and tumor necros ...... beta-adrenergic responsiveness

@nl

P1433

Q34301819-0560D99F-2C2C-40F1-A119-93FC2E94FBDB

P1476

Q34301819-6906C1D3-04D6-45DB-97F7-4C5FA55D1FA3

P2093

Q34301819-1D7E3794-B3C0-4635-9EC1-4F50D98B194C

Q34301819-3A7BF7C8-B269-498C-A1C7-C9B7C98EA4F9

Q34301819-5B7076A4-99E3-4F05-B6AD-939986D26589

Q34301819-674B5C76-A219-44A4-892B-29D49D8C6E79

Q34301819-E96F12DA-A9F6-483D-A3FA-E9F4248D6C62

P2860

Q34301819-45B174DA-C7B2-4FD5-9D73-37FC4277422F

Q34301819-62E65D7B-5070-4E87-B66C-353105B0C8E7

Q34301819-7D2B46C7-32F2-413A-9C29-5AF9409C3586

Q34301819-881DDB2A-CA00-425F-AAFA-8288420E04ED

Q34301819-95691F4C-A7AA-4B61-891E-443F22D0228D

Q34301819-9CCF7D76-1073-459E-BD7F-CC7252CD9327

Q34301819-B1BEE6C7-F45A-40C7-959E-75607A7F8F2D

Q34301819-C6F0DC91-3CF7-417C-8866-DCF759166769

Q34301819-CA373631-C759-46A3-ACAE-27A60AB3C168

Q34301819-FED0AC09-AFD7-4DE2-924B-62EF6B014AC3

P304

Q34301819-33BD46BB-B3CA-47BE-B262-AC5980B809C2

P31

Q34301819-CEB0F758-5CF9-4215-BE99-B75AD46963AA

P356

Q34301819-86676832-68B4-4F38-8C2C-AE535E0DC9BC

P407

Q34301819-D7A039C2-1971-4ECB-A47F-910665956AEF

P433

Q34301819-77DAA10B-31A6-494B-8750-046CCE1C58C0

P478

Q34301819-C654B576-D915-44C8-97BF-054FE472842B

P577

Q34301819-2E206D6B-D26E-4A10-98DC-78183DDEB23A

P5875

Q34301819-BC75516D-2EE8-4371-AA36-DF540216F7BD

P698

Q34301819-AACF2E47-4C6C-46F5-B1E9-DCFB634431D0

P921

Q34301819-1db39a2e-7a60-45e8-8326-0e7012458d7b

P932

Q34301819-D272F28E-4090-4C73-BA97-D95A1352BF9A

P356

PNAS.86.17.6753

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Interleukin 1 and tumor necros ...... beta-adrenergic responsiveness

@en

P2093

Chung MK

http://www.w3.org/2001/XMLSchema#string

Gulick T

http://www.w3.org/2001/XMLSchema#string

Lange LG

http://www.w3.org/2001/XMLSchema#string

Pieper SJ

http://www.w3.org/2001/XMLSchema#string

Schreiner GF

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Interleukin 1 inhibits contraction of vascular smooth muscle.

Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells.

Leukocytic infiltrates in idiopathic dilated cardiomyopathy. A source of confusion with active myocarditis.

Cardiac transplantation: immune mechanisms and alloantigens involved in graft rejection.

Rejection of the transplanted heart.

Myocarditis and dilated cardiomyopathy.

Immune cytokine inhibition of beta-adrenergic agonist stimulated cyclic AMP generation in cardiac myocytes.

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

[3H]CGP-12177, a beta-adrenergic ligand suitable for measuring cell surface receptors.

P304

6753-6757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.86.17.6753

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

1989-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20605699

http://www.w3.org/2001/XMLSchema#string

P698

2549546

http://www.w3.org/2001/XMLSchema#string

P921

P932

297924

http://www.w3.org/2001/XMLSchema#string